Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo US Bio-TechNSE:INDOUS -1.06%64 3-Year ROIIC % is 11.61 as of Mar. 2026, which is 16% below its 10-year median of 13.74. GuruFocus rates NSE:INDOUS with a GF Score™ of 64/100 and a GF Value™ of ₹315.11 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 252 Agriculture companies, Indo US Bio-Tech ranks better than 71.03% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Indo US Bio-Tech's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 11.61%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Indo US Bio-Tech's 3-Year ROIIC % or its related term are showing as below:
NSE:INDOUS's 3-Year ROIIC % is ranked better than 71.03% of 252
companies
in the Agriculture industry
Industry Median: -1.615
vs NSE:INDOUS: 11.61
Indo US Bio-Tech (NSE:INDOUS) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Indo US Bio-Tech 3-Year ROIIC % Related Terms
Indo US Bio-Tech 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: 3-Year ROIIC % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech 3-Year ROIIC % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Indo US Bio-Tech (NSE:INDOUS) has a 3-Year ROIIC % of 11.61 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Indo US Bio-Tech and its competitors. This is 16% below median its historical median of 13.74. Over the past decade, Indo US Bio-Tech's 3-Year ROIIC % has ranged from 10.25 to 25.66. According to the industry distribution chart, Indo US Bio-Tech ranks #73 out of 252 companies in the Agriculture industry, placing it in the top 29%.
Is Indo US Bio-Tech's 3-Year ROIIC % too high?
Indo US Bio-Tech's current 3-Year ROIIC % of 11.61 is 16% below median its 10-year median of 13.74. Over the past 10 years, this metric has ranged from a low of 10.25 to a high of 25.66. Based on the distribution chart, Indo US Bio-Tech ranks #73 out of 252 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's 3-Year ROIIC % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #73 out of 252 companies for 3-Year ROIIC %. This puts Indo US Bio-Tech in the upper half of its industry. Historically, Indo US Bio-Tech's own 3-Year ROIIC % has ranged from 10.25 to 25.66 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for an Agriculture company?
A good 3-Year ROIIC % depends on the Agriculture industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current 3-Year ROIIC % is 11.61, which is 16% below median its own 10-year median of 13.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹315.11, compared to a current price of ₹84.10 — trading 73.3% below its estimated fair value. The current 3-Year ROIIC % is 11.61, which is 16% below median its 10-year median of 13.74. Indo US Bio-Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current 3-Year ROIIC % is 11.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹84.10 is trading 73.3% below its estimated GF Value™ of ₹315.11.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
3-Year ROIIC %: 11.61 (16% below median its 10-year median of 13.74)
GF Value™: ₹315.11 vs. price of ₹84.10 (73.3% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
64GF Score
Get the complete analysis for NSE:INDOUS
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
